TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.
TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.
复制标题
TB还是TB?对假定为耐多药结核病的成人未处理痰液中结核分枝杆菌复合群内的菌种进行连续测定
DOI:
10.1111/tmi.13638
复制
发表时间:
2021-09
期刊:
影响因子:
--
通讯作者:
Mpagama S
中科院分区:
文献类型:
--
作者:
Mbelele PM;Sauli E;Mpolya EA;Mohamed SY;Addo KK;Mfinanga SG;Heysell SK;Mpagama S
Differences among Mycobacterium tuberculosis complex (MTC) species may predict drug resistance or treatment success. Thus, we optimised and deployed the genotype MTBC assay (gMTBC) to identify MTC to the species level, and then performed comparative genotypic drug‐susceptibility testing to anti‐tuberculosis drugs from direct sputum of patients with presumed multidrug‐resistant tuberculosis (MDR‐TB) by the MTBDRplus/sl reference method. Patients with positive Xpert® MTB/RIF (Xpert) results were consented to provide early‐morning‐sputum for testing by the gMTBC and the reference MTBDRplus/sl. Chi‐square or Fisher’s exact test compared proportions. Modified Poisson regression modelled detection of MTC by gMTBC. Among 73 patients, 53 (73%) were male and had a mean age of 43 (95% CI; 40–45) years. In total, 34 (47%), 36 (49%) and 38 (55%) had positive gMTBC, culture and MTBDR respectively. Forty patients (55%) had low quantity MTC by Xpert, including 31 (78%) with a negative culture. gMTBC was more likely to be positive in patients with chest cavity 4.18 (1.31–13.32, P = 0.016), high‐quantity MTC by Xpert 3.03 (1.35–6.82, P = 0.007) and sputum smear positivity 1.93 (1.19–3.14, P = 0.008). The accuracy of gMTBC in detecting MTC was 95% (95% CI; 86–98; κ = 0.89) compared to MTBDRplus/sl. All M. tuberculosis/canettii identified by gMTB were susceptible to fluoroquinolone and aminoglycosides/capreomycin. The concordance between the gMTBC assay and MTBDRplus/sl in detecting MTC was high but lagged behind the yield of Xpert MTB/RIF. All M. tuberculosis/canettii were susceptible to fluoroquinolones, a core drug in MDR‐TB treatment regimens.
登录
查看更多内容
影响因子:
30.8
作者:
Manson AL;Cohen KA;Abeel T;Desjardins CA;Armstrong DT;Barry CE 3rd;Brand J;TBResist Global Genome Consortium;Chapman SB;Cho SN;Gabrielian A;Gomez J;Jodals AM;Joloba M;Jureen P;Lee JS;Malinga L;Maiga M;Nordenberg D;Noroc E;Romancenco E;Salazar A;Ssengooba W;Velayati AA;Winglee K;Zalutskaya A;Via LE;Cassell GH;Dorman SE;Ellner J;Farnia P;Galagan JE;Rosenthal A;Crudu V;Homorodean D;Hsueh PR;Narayanan S;Pym AS;Skrahina A;Swaminathan S;Van der Walt M;Alland D;Bishai WR;Cohen T;Hoffner S;Birren BW;Earl AM
通讯作者:
Earl AM
DOI:
10.5588/ijtld.20.0906
发表时间:
2021-04-01
期刊:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
影响因子:
--
作者:
Allwood BW;Stolbrink M;Baines N;Louw E;Wademan DT;Lupton-Smith A;Nel S;Maree D;Mpagama S;Osman M;Marx FM;Hoddinott G;Lesosky M;Rylance J;Mortimer K
通讯作者:
Mortimer K
影响因子:
3.6
作者:
Alipanah, Narges;Shete, Priya B.;Nahid, Payam
通讯作者:
Nahid, Payam
影响因子:
4.9
作者:
Loiseau, Chloe;Brites, Daniela;Koser, Claudio U.
通讯作者:
Koser, Claudio U.
影响因子:
3.1
作者:
Hoza, Ha Abubakar S.;Mfinanga, Sayoki G. M.;Koenig, Brigitte
通讯作者:
Koenig, Brigitte